DRKS00030300招募中不适用
Prevalence of somatic and germline mutations in patients with Primary or relapsed endometrial carcinomas - AGO-TR 2
AGO Research GmbH, AGO Studiengruppe0 个研究点目标入组 400 人开始时间: 2022年11月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Female
入选标准
- •1. Signed written informed consent.
- •2. Patients = 18 years with primary or any relapsed endometrial carcinomas (all subtypes), diagnosed or treated within the last 6 months.
- •3. Available tumor samples (tumor tissue sample of primary diagnosis and/or relapsed disease if available). For early stage disease 1st priority sample: tumor from hysterectomy specimen. If not sufficient tumor load is present 2nd priority sample: tumor from dilation and curettage (D&C). For relapsed patients, tumor sample from time of relapse would be preferred.
排除标准
- •1. Non-invasive carcinomas or precancerous lesions. (History of prior malignancy is allowed).
- •2. No available tumor sample
- •3. Missing informed consent
- •4. Any medical condition preventing informed consent
- •5. Failure to consent to registration, not willing to storageallow storage or handling of personal information, blood or tumor samples, or not willing to participate in assessment of family history.
研究者
相似试验
已完成
不适用
Analysis of multiplex somatic mutation profile and its prognostic values of non-small cell lung cancer using next generation sequencer (WJOG7914LTR)SCLCJPRN-UMIN000015018West Japan Oncology Group322
已完成
不适用
Study on the incidence of genetic polymorphism in patients with major depression who are treated unsatisfactory with antidepressantsGenetic polymorphism of drug metabolizingF32.2Severe depressive episode without psychotic symptomsDRKS00013497STADAPHARM GmbH252
已完成
不适用
Influence of somatic mutational status of DNA repair genes on the clinical course in men with High risk-prostate cancer - a prospective biomarker studyHigh grade prostate carcinomaC61Malignant neoplasm of prostateDRKS00015159niversitätsklinikum Heidelberg Nationales Centrum für Tumorerkrankungen (NCT) Medizinische Onkologie und Urologische Klinik197
进行中（未招募）
不适用
A study to assess the incidence in the UK of a change in a protein found in patients with newly diagnosed non-small cell lung cancer which has advanced or spread, and to investigate the quality of life of these patients when they receive treatment with erlotinib (Tarceva®) alone as a first treatment for this stage of their disease.EUCTR2010-021120-96-GBRoche Products Limited1,200
招募中
不适用
Identification of germline mutations in familial and extremely early-onset urinary bladder cancerbladder papilloma10038364bladder cancerNL-OMON41769niversitair Medisch Centrum Sint Radboud585